Table 4.
Outcomes
| Outcome | Y2 (n = 673) | Y1 (n = 693) | p Value* | TR (n = 194) | TF (n = 1,172) | p Value* |
|---|---|---|---|---|---|---|
| Bleeding or Vascular Complications | 5 (0.7%) | 14 (2.0%) | 0.05 | 0 (0.0%) | 19 (1.6%) | 0.1† |
| Bleeding Complications | 4 (0.6%) | 8 (1.2%) | 0.3 | 0 (0.0%) | 12 (1.0%) | 0.2† |
| Access Site Bleeding or Hematoma | 2 (0.3%) | 3 (0.4%) | - | 0 (0.0%) | 5 (0.4%) | - |
| Retroperitoneal Bleeding | 2 (0.3%) | 3 (0.4%) | - | 0 (0.0%) | 5 (0.4%) | - |
| Gastrointestinal Bleeding | 0 (0.0%) | 2 (0.3%) | - | 0 (0.0%) | 2 (0.2%) | - |
| Vascular Complications | 1 (0.1%) | 6 (0.9%) | 0.1 | 0 (0.0%) | 7 (0.6%) | 0.6† |
| Pseudoaneurysm | 0 (0.0%) | 5 (0.7%) | - | 0 (0.0%) | 5 (0.4%) | - |
| Arteriovenous Fistula | 0 (0.0%) | 1 (0.1%) | - | 0 (0.0%) | 1 (0.1%) | - |
| Arterial Dissection | 1 (0.1%) | 0 (0.0%) | - | 0 (0.0%) | 1 (0.1%) | - |
| Pre-discharge Mortality | 7 (1.0%) | 8 (1.2%) | 0.8 | 1 (0.5%) | 14 (1.2%) | 0.4 |
| Procedural Success | 653 (97.0%) | 670 (96.7%) | 0.7 | 190 (97.9%) | 1,133 (96.7%) | 0.4 |
| Length of Stay (days) | 3.1 (12.5) | 2.9 (5.8) | 0.6 | 2.5 (4.0) | 3.1 (10.3) | 0.4 |
Data are presented as means (standard deviations) and n (%), which are raw values and do not account for multiple observations per individual patient. Abbreviations as in Table 1.
*
P-values take into consideration the fact that some observations were made on the same individuals.
†
For comparisons with a zero cell, Fisher’s exact tests were used.